Compare DAWN & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAWN | CRON |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2021 | 2015 |
| Metric | DAWN | CRON |
|---|---|---|
| Price | $12.02 | $2.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $27.56 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 56.96 | ★ 157.89 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $131,161,000.00 | $117,615,000.00 |
| Revenue This Year | $18.59 | $18.81 |
| Revenue Next Year | $49.98 | $34.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 34.82 |
| 52 Week Low | $5.64 | $1.60 |
| 52 Week High | $13.20 | $3.43 |
| Indicator | DAWN | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 57.55 | 52.60 |
| Support Level | $10.07 | $2.44 |
| Resistance Level | $13.20 | $2.77 |
| Average True Range (ATR) | 0.67 | 0.08 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 92.16 | 62.50 |
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.